vs

Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Healthcare Realty Trust Inc (HR). Click either name above to swap in a different company.

Healthcare Realty Trust Inc is the larger business by last-quarter revenue ($279.0M vs $196.0M, roughly 1.4× Axsome Therapeutics, Inc.). Healthcare Realty Trust Inc runs the higher net margin — -0.0% vs -14.6%, a 14.6% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 5.9%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs -6.1%).

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

Duke Realty was a real estate investment trust (REIT) based in Indianapolis, Indiana, that invested in industrial properties. As of December 31, 2021, it owned or jointly controlled 548 primarily industrial properties containing 162.7 million rentable square feet. In October 2022, it was acquired by Prologis.

AXSM vs HR — Head-to-Head

Bigger by revenue
HR
HR
1.4× larger
HR
$279.0M
$196.0M
AXSM
Growing faster (revenue YoY)
AXSM
AXSM
+59.1% gap
AXSM
65.0%
5.9%
HR
Higher net margin
HR
HR
14.6% more per $
HR
-0.0%
-14.6%
AXSM
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
61.7%
-6.1%
HR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
AXSM
AXSM
HR
HR
Revenue
$196.0M
$279.0M
Net Profit
$-28.6M
$-56.0K
Gross Margin
Operating Margin
-13.8%
Net Margin
-14.6%
-0.0%
Revenue YoY
65.0%
5.9%
Net Profit YoY
61.9%
EPS (diluted)
$-0.55
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXSM
AXSM
HR
HR
Q1 26
$279.0M
Q4 25
$196.0M
$286.3M
Q3 25
$171.0M
$297.8M
Q2 25
$150.0M
$297.5M
Q1 25
$121.5M
$299.0M
Q4 24
$118.8M
$309.8M
Q3 24
$104.8M
$315.4M
Q2 24
$87.2M
$316.3M
Net Profit
AXSM
AXSM
HR
HR
Q1 26
$-56.0K
Q4 25
$-28.6M
$14.6M
Q3 25
$-47.2M
$-57.7M
Q2 25
$-48.0M
$-157.9M
Q1 25
$-59.4M
$-44.9M
Q4 24
$-74.9M
$-108.2M
Q3 24
$-64.6M
$-93.0M
Q2 24
$-79.3M
$-143.8M
Operating Margin
AXSM
AXSM
HR
HR
Q1 26
Q4 25
-13.8%
Q3 25
-27.0%
Q2 25
-24.5%
Q1 25
-46.9%
Q4 24
-61.1%
Q3 24
-59.8%
Q2 24
-89.5%
Net Margin
AXSM
AXSM
HR
HR
Q1 26
-0.0%
Q4 25
-14.6%
183.4%
Q3 25
-27.6%
-19.4%
Q2 25
-32.0%
-53.1%
Q1 25
-48.9%
-15.0%
Q4 24
-63.1%
-1924.1%
Q3 24
-61.7%
-29.5%
Q2 24
-91.0%
-45.5%
EPS (diluted)
AXSM
AXSM
HR
HR
Q1 26
$0.00
Q4 25
$-0.55
$0.04
Q3 25
$-0.94
$-0.17
Q2 25
$-0.97
$-0.45
Q1 25
$-1.22
$-0.13
Q4 24
$-1.54
$-0.34
Q3 24
$-1.34
$-0.26
Q2 24
$-1.67
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXSM
AXSM
HR
HR
Cash + ST InvestmentsLiquidity on hand
$322.9M
$26.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$88.3M
$4.4B
Total Assets
$689.8M
$9.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXSM
AXSM
HR
HR
Q1 26
$26.2M
Q4 25
$322.9M
$26.2M
Q3 25
$325.3M
$43.3M
Q2 25
$303.0M
$25.5M
Q1 25
$300.9M
$25.7M
Q4 24
$315.4M
$68.9M
Q3 24
$327.3M
$22.8M
Q2 24
$315.7M
$41.8M
Total Debt
AXSM
AXSM
HR
HR
Q1 26
Q4 25
$3.9B
Q3 25
$4.5B
Q2 25
$4.7B
Q1 25
$4.7B
Q4 24
$4.7B
Q3 24
$5.0B
Q2 24
$5.1B
Stockholders' Equity
AXSM
AXSM
HR
HR
Q1 26
$4.4B
Q4 25
$88.3M
$4.6B
Q3 25
$73.7M
$4.7B
Q2 25
$73.1M
$4.8B
Q1 25
$53.2M
$5.1B
Q4 24
$57.0M
$5.2B
Q3 24
$92.9M
$5.5B
Q2 24
$102.9M
$5.9B
Total Assets
AXSM
AXSM
HR
HR
Q1 26
$9.1B
Q4 25
$689.8M
$9.2B
Q3 25
$669.3M
$9.9B
Q2 25
$639.8M
$10.2B
Q1 25
$596.7M
$10.5B
Q4 24
$568.5M
$10.7B
Q3 24
$561.5M
$11.2B
Q2 24
$548.2M
$11.8B
Debt / Equity
AXSM
AXSM
HR
HR
Q1 26
Q4 25
0.85×
Q3 25
0.96×
Q2 25
0.97×
Q1 25
0.93×
Q4 24
0.89×
Q3 24
0.90×
Q2 24
0.87×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXSM
AXSM
HR
HR
Operating Cash FlowLast quarter
$-18.7M
Free Cash FlowOCF − Capex
$-18.7M
FCF MarginFCF / Revenue
-9.6%
Capex IntensityCapex / Revenue
0.0%
9.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXSM
AXSM
HR
HR
Q1 26
Q4 25
$-18.7M
$457.1M
Q3 25
$1.0M
$113.8M
Q2 25
$-32.4M
$163.2M
Q1 25
$-43.4M
$47.8M
Q4 24
$-26.2M
$501.6M
Q3 24
$-18.6M
$119.3M
Q2 24
$-30.1M
$168.2M
Free Cash Flow
AXSM
AXSM
HR
HR
Q1 26
Q4 25
$-18.7M
Q3 25
$988.0K
Q2 25
$-32.4M
Q1 25
$-43.7M
Q4 24
$-26.2M
Q3 24
$-18.7M
Q2 24
$-30.2M
FCF Margin
AXSM
AXSM
HR
HR
Q1 26
Q4 25
-9.6%
Q3 25
0.6%
Q2 25
-21.6%
Q1 25
-36.0%
Q4 24
-22.1%
Q3 24
-17.9%
Q2 24
-34.6%
Capex Intensity
AXSM
AXSM
HR
HR
Q1 26
9.7%
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.3%
Q4 24
0.0%
Q3 24
0.1%
Q2 24
0.1%
Cash Conversion
AXSM
AXSM
HR
HR
Q1 26
Q4 25
31.33×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXSM
AXSM

Segment breakdown not available.

HR
HR

Rental income$267.6M96%
Other$11.4M4%

Related Comparisons